Search research articles
Contact Us
Filters
Showing results (1371-1380 of 1,457) with videos related to
Page
of 146
Sort By:
Neuro-Oncology
|
April 4, 2017
Is more better? The impact of extended adjuvant temozolomide in newly diagnosed glioblastoma: a secondary analysis of EORTC and NRG Oncology/RTOG
Deborah T Blumenthal, Thierry Gorlia, Mark R Gilbert, et al.
Annals of Human Genetics
|
May 22, 2009
A genome-wide association study of autism reveals a common novel risk locus at 5p14.1
Deqiong Ma, Daria Salyakina, James M Jaworski, et al.
The New England Journal of Medicine
|
February 21, 2014
A randomized trial of bevacizumab for newly diagnosed glioblastoma
Mark R Gilbert, James J Dignam, Terri S Armstrong, et al.
Neuro-Oncology Practice
|
July 19, 2021
Systematic review on the use of patient-reported outcome measures in brain tumor studies: part of the Response Assessment in Neuro-Oncology Patient-Reported Outcome (RANO-PRO) initiative
Linda Dirven, Maartje E Vos, Tobias Walbert, et al.
JCI Insight
|
January 26, 2021
Developmental vascular malformations in EPAS1 gain-of-function syndrome
Jared S Rosenblum, Herui Wang, Pauline M Dmitriev, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
August 28, 2012
Phase I study of vorinostat in combination with temozolomide in patients with high-grade gliomas: North American Brain Tumor Consortium Study 04-03
Eudocia Q Lee, Vinay K Puduvalli, Joel M Reid, et al.
Neuro-Oncology
|
August 22, 2024
Distinct relapse pattern across molecular ependymoma types
Denise Obrecht-Sturm, Melanie Schoof, Alicia Eckhardt, et al.
Neuro-Oncology Advances
|
March 23, 2026
Discovery of genetic susceptibility variants in pediatric and adult ependymoma
Joshua D Strauss, Priya B Shetty, Spiridon Tsavachidis, et al.
Neuro-Oncology Advances
|
April 24, 2026
Combination of metronomic oral pazopanib and topotecan for recurrent glioblastoma with and without previous bevacizumab: Results from a phase 2 clinical trial
Byram H Ozer, Adam L Cohen, Howard Colman, et al.
Neuro-Oncology
|
September 23, 2021
Impact of the methylation classifier and ancillary methods on CNS tumor diagnostics
Zhichao Wu, Zied Abdullaev, Drew Pratt, et al.
Page
of 146
Search research articles
Search
Showing results (1371-1380 of 1,457) with videos related to
Sort By:
Page
of 146
Neuro-Oncology
|
April 4, 2017
Is more better? The impact of extended adjuvant temozolomide in newly diagnosed glioblastoma: a secondary analysis of EORTC and NRG Oncology/RTOG
Deborah T Blumenthal, Thierry Gorlia, Mark R Gilbert, et al.
Annals of Human Genetics
|
May 22, 2009
A genome-wide association study of autism reveals a common novel risk locus at 5p14.1
Deqiong Ma, Daria Salyakina, James M Jaworski, et al.
The New England Journal of Medicine
|
February 21, 2014
A randomized trial of bevacizumab for newly diagnosed glioblastoma
Mark R Gilbert, James J Dignam, Terri S Armstrong, et al.
Neuro-Oncology Practice
|
July 19, 2021
Systematic review on the use of patient-reported outcome measures in brain tumor studies: part of the Response Assessment in Neuro-Oncology Patient-Reported Outcome (RANO-PRO) initiative
Linda Dirven, Maartje E Vos, Tobias Walbert, et al.
JCI Insight
|
January 26, 2021
Developmental vascular malformations in EPAS1 gain-of-function syndrome
Jared S Rosenblum, Herui Wang, Pauline M Dmitriev, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
August 28, 2012
Phase I study of vorinostat in combination with temozolomide in patients with high-grade gliomas: North American Brain Tumor Consortium Study 04-03
Eudocia Q Lee, Vinay K Puduvalli, Joel M Reid, et al.
Neuro-Oncology
|
August 22, 2024
Distinct relapse pattern across molecular ependymoma types
Denise Obrecht-Sturm, Melanie Schoof, Alicia Eckhardt, et al.
Neuro-Oncology Advances
|
March 23, 2026
Discovery of genetic susceptibility variants in pediatric and adult ependymoma
Joshua D Strauss, Priya B Shetty, Spiridon Tsavachidis, et al.
Neuro-Oncology Advances
|
April 24, 2026
Combination of metronomic oral pazopanib and topotecan for recurrent glioblastoma with and without previous bevacizumab: Results from a phase 2 clinical trial
Byram H Ozer, Adam L Cohen, Howard Colman, et al.
Neuro-Oncology
|
September 23, 2021
Impact of the methylation classifier and ancillary methods on CNS tumor diagnostics
Zhichao Wu, Zied Abdullaev, Drew Pratt, et al.
Page
of 146